Related Experiment Video
Updated: Jan 30, 2026

09:45
Radiosensitivity of Cancer Stem Cells in Lung Cancer Cell Lines
Published on: August 21, 2019
7.5K
Chemotherapy and cancer stem cells.
1Department of Medicine, Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC 27710, USA. rich0001@mc.duke.edu
Cell Stem Cell
|March 29, 2008
Summary
Targeting interleukin-4 (IL-4) in tumors can make colon cancer stem cells more sensitive to chemotherapy. This approach offers a new strategy for overcoming treatment resistance in colon cancer.
Area of Science:
- Oncology
- Cancer Biology
- Stem Cell Research
Background:
- Cancer stem cells (CSCs) are crucial for tumor initiation and recurrence.
- CSCs are often resistant to conventional chemotherapy, contributing to treatment failure.
- Interleukin-4 (IL-4) has been implicated in tumor microenvironment modulation.
Purpose of the Study:
- To investigate the role of IL-4 in colon cancer stem cell (CCSC) biology.
- To determine if targeting IL-4 can enhance the efficacy of chemotherapy against CCSCs.
- To explore novel therapeutic strategies for overcoming chemoresistance in colon cancer.
Main Methods:
- Utilized in vitro models of colon cancer stem cells.
- Assessed the effects of IL-4 manipulation on CCSC proliferation and survival.
- Evaluated the combined effects of IL-4 targeting and chemotherapy agents on CCSCs.
Main Results:
- Demonstrated that IL-4 contributes to the survival and chemoresistance of colon cancer stem cells.
- Showed that inhibiting IL-4 signaling sensitizes CCSCs to standard chemotherapy.
- Identified a potential mechanism by which IL-4 promotes therapeutic resistance.
Conclusions:
- Targeting tumor-associated IL-4 is a promising strategy to overcome chemotherapy resistance in colon cancer.
- This approach may improve treatment outcomes for patients with colon cancer by eliminating cancer stem cells.
- Further research into IL-4 targeted therapies for cancer is warranted.
Related Concept Videos
Distinctive Features of Adult Stem Cells vs Cancer Stem Cells
4.5K
A stem cell is an unspecialized cell that can divide without limit as needed and can, under specific conditions, differentiate into specialized cells.
Adult stem cells
Adult stem cells are tissue-specific; hence, they divide to develop the tissue from which they originate. One type of adult stem cell is the epithelial stem cell, which gives rise to the keratinocytes in the multiple layers of epithelial cells in the epidermis of the skin. Adult bone marrow has three distinct types of stem cells:...
Adult stem cells
Adult stem cells are tissue-specific; hence, they divide to develop the tissue from which they originate. One type of adult stem cell is the epithelial stem cell, which gives rise to the keratinocytes in the multiple layers of epithelial cells in the epidermis of the skin. Adult bone marrow has three distinct types of stem cells:...
4.5K
Cancer Stem Cells and Tumor Maintenance
6.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.0K
Adult Stem Cells
33.8K
Stem cells are undifferentiated cells that divide and produce more stem cells or progenitor cells that differentiate into mature, specialized cell types. All the cells in the body are generated from stem cells in the early embryo, but small populations of stem cells are also present in many adult tissues including the bone marrow, brain, skin, and gut. These adult stem cells typically produce the various cell types found in that tissue—to replace cells that are damaged or to continuously...
33.8K
Embryonic Stem Cells
32.4K
Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
32.4K
Embryonic Stem Cells
5.0K
Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
5.0K
Induced Pluripotent Stem Cells
28.0K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
28.0K

